Development of Membrane-Targeting Cannabigerol Derivatives as Potent Broad-Spectrum Antibacterial Agents
Drug Design, Development and Therapy · 2026
DOI: 10.2147/dddt.s558606 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026. Verfasst von Zhicheng Yin und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Microbial Technology, Microbial Technology Institute, Shandong University, Qingdao, People's Republic of China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Gram-Negative Bacteria, Gram-Positive Bacteria, Cell Membrane. Die Arbeit nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Microbial Technology, Microbial Technology Institute, Shandong University, Qingdao, People's Republic of China.
ORCID-Profile: Chuandong Wang
Zitieren
APA
Yin, Z., Zhang, T., Wang, Y., Wang, Y., Xie, X., Zhang, F., Wang, C., & Hu, W. (2026). Development of Membrane-Targeting Cannabigerol Derivatives as Potent Broad-Spectrum Antibacterial Agents. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s558606
Vancouver
Yin Z, Zhang T, Wang Y, Wang Y, Xie X, Zhang F, et al. Development of Membrane-Targeting Cannabigerol Derivatives as Potent Broad-Spectrum Antibacterial Agents. Drug Design, Development and Therapy. 2026. doi:10.2147/dddt.s558606
BibTeX
@article{Yin2026,
author = {Yin, Zhicheng and Zhang, Tingting and Wang, Yipeng and Wang, Yan and Xie, Xiaoqing and Zhang, Fengyu and Wang, Chuandong and Hu, Wei},
title = {Development of Membrane-Targeting Cannabigerol Derivatives as Potent Broad-Spectrum Antibacterial Agents},
journal = {Drug Design, Development and Therapy},
year = {2026},
doi = {10.2147/dddt.s558606}
}
EUVIMED